Paper22006014
Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality.
Scosyrev E and 4 others. Cancer, 2012. Cited by 157 papers, by iCite.
Cite this record
ConductScience Library. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. Papers, record 22006014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22006014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Age Distribution | |
| Aged | |
| Aged, 80 and over | |
| Humans | |
| Incidence | |
| Male | |
| Middle Aged | |
| Neoplasm Metastasis |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01859221 | Radiotherapy for Oligometastatic Prostate Cancer | Background |
Source ClinicalTrials.gov
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 22006679 | A tale of 2 perspectives: the clinician and the public health professional. | https://conductscience.org/library/papers/22006679 | PubMed |
| Comment in | 22579175 | Re: Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. | https://conductscience.org/library/papers/22579175 | PubMed |
| Comment in | 22784726 | Re: Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. | https://conductscience.org/library/papers/22784726 | PubMed |
Cited by75
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42781478 | Predicting disease progression and mortality in prostate cancer using real-world data-driven time-inhomogeneous Markov models. | iScience | 2026 | https://conductscience.org/library/papers/42781478 | PubMed |
| 42255745 | Definitive Radiation Therapy for Older Adults With Localized Prostate Cancer. | Cureus | 2026 | https://conductscience.org/library/papers/42255745 | PubMed |
| 42154021 | [Reassessing androgen deprivation therapy (ADT) in older men with advanced prostate cancer: when to use, when to discontinue, and role as monotherapy?] | Urologie | 2026 | https://conductscience.org/library/papers/42154021 | PubMed |
| 42036417 | Advanced age increases cancer-specific mortality in bone-only metastatic prostate cancer: a SEER analysis. | Sci Rep | 2026 | https://conductscience.org/library/papers/42036417 | PubMed |
| 41801523 | Predictive value of interim ¹¹C-choline PET/CT for response to radium-223 in metastatic castration-resistant prostate cancer. | EJNMMI Res | 2026 | https://conductscience.org/library/papers/41801523 | PubMed |
| 41787493 | Outcomes of Retzius-sparing robot-assisted radical prostatectomy in men aged ≥ 75 years. | BMC Urol | 2026 | https://conductscience.org/library/papers/41787493 | PubMed |
| 41303903 | Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41303903 | PubMed |
| 40720255 | Metabolic adaptations in cancer progression. | Physiol Rev | 2026 | https://conductscience.org/library/papers/40720255 | PubMed |
| 40150825 | Castration-Resistant Prostate Cancer Presenting as Bulky Lymphadenopathy: A Case without Bone Metastasis. | Am J Case Rep | 2025 | https://conductscience.org/library/papers/40150825 | PubMed |
| 40067073 | Evaluation of Mortality Risk Factors in Prostate Cancer: Impact of Demographic, Clinical, Laboratory, Therapeutic, and Trace Element Influences. | Cancer Rep (Hoboken) | 2025 | https://conductscience.org/library/papers/40067073 | PubMed |
| 39682181 | Survival Outcomes for Men over 80 Years Undergoing Transrectal Ultrasound-Guided Prostate Biopsy: A Prospective Analysis. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682181 | PubMed |
| 39641342 | A Rare Cause of Mechanical Icterus: Prostate Cancer Metastasis. | Turk J Gastroenterol | 2024 | https://conductscience.org/library/papers/39641342 | PubMed |
| 39040620 | Survival Patterns Based on First-site-specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same? | Eur Urol Open Sci | 2024 | https://conductscience.org/library/papers/39040620 | PubMed |
| 38893199 | Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38893199 | PubMed |
| 38418470 | Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study. | Sci Rep | 2024 | https://conductscience.org/library/papers/38418470 | PubMed |
| 38291265 | Metastatic Hormone-Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy. | Curr Treat Options Oncol | 2024 | https://conductscience.org/library/papers/38291265 | PubMed |
| 37658924 | Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients. | Strahlenther Onkol | 2024 | https://conductscience.org/library/papers/37658924 | PubMed |
| 37450026 | Development and external validation of a novel prognostic nomogram for overall survival in prostate cancer patients with bone metastatic: a retrospective study of the SEER-based and a single Chinese center. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37450026 | PubMed |
| 36864360 | 225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings. | Eur J Nucl Med Mol Imaging | 2023 | https://conductscience.org/library/papers/36864360 | PubMed |
| 36291845 | Surgical Tolerability and Frailty in Elderly Patients Undergoing Robot-Assisted Radical Prostatectomy: A Narrative Review. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291845 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22006014
GET https://conductscience.org/api/papers/v1/22006014/cited_by?page=2